United States Metabolism Drugs Market Report 2017

February 2017 | 101 pages | ID: U1725ED2E33EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Metabolism Drugs

Revenue, means the sales value of Metabolism Drugs

This report studies sales (consumption) of Metabolism Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Merck
• Novartis
• Takeda Pharmaceutical
• Astra Zeneca
• Beohrigher Ingelheim
• KOWA
• Kythera
• Fuji yakuhin
• LG Life Science
• Metsubishi Tanabe Pharma

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Glycogen Metabolism Disease Drug
• Lipid Metabolism Disease Drug
• Amino Acid Metabolism Drug
• Other

Split by applications, this report focuses on sales, market share and growth rate of Metabolism Drugs in each application, can be divided into

• Hospital
• Retail Pharmacy
• Other

Contents

United States Metabolism Drugs Market Report 2017

1 METABOLISM DRUGS OVERVIEW

1.1 Product Overview and Scope of Metabolism Drugs
1.2 Classification of Metabolism Drugs
  1.2.1 Glycogen Metabolism Disease Drug
  1.2.2 Lipid Metabolism Disease Drug
  1.2.3 Amino Acid Metabolism Drug
  1.2.4 Other
1.3 Application of Metabolism Drugs
  1.3.1 Hospital
  1.3.2 Retail Pharmacy
  1.3.3 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Metabolism Drugs (2012-2022)
  1.4.1 United States Metabolism Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Metabolism Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES METABOLISM DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Metabolism Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Metabolism Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Metabolism Drugs Average Price by Manufactures (2015 and 2016)
2.4 Metabolism Drugs Market Competitive Situation and Trends
  2.4.1 Metabolism Drugs Market Concentration Rate
  2.4.2 Metabolism Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES METABOLISM DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Metabolism Drugs Sales and Market Share by States (2012-2017)
3.2 United States Metabolism Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Metabolism Drugs Price by States (2012-2017)

4 UNITED STATES METABOLISM DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Metabolism Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Metabolism Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Metabolism Drugs Price by Type (2012-2017)
4.4 United States Metabolism Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES METABOLISM DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Metabolism Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Metabolism Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES METABOLISM DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Metabolism Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Metabolism Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceutical
  6.3.2 Metabolism Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceutical Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Astra Zeneca
  6.4.2 Metabolism Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Astra Zeneca Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Beohrigher Ingelheim
  6.5.2 Metabolism Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Beohrigher Ingelheim Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 KOWA
  6.6.2 Metabolism Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 KOWA Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Kythera
  6.7.2 Metabolism Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Kythera Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Fuji yakuhin
  6.8.2 Metabolism Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 LG Life Science
  6.9.2 Metabolism Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Metsubishi Tanabe Pharma
  6.10.2 Metabolism Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 METABOLISM DRUGS MANUFACTURING COST ANALYSIS

7.1 Metabolism Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Metabolism Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Metabolism Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES METABOLISM DRUGS MARKET FORECAST (2017-2022)

11.1 United States Metabolism Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Metabolism Drugs Sales Forecast by Type (2017-2022)
11.3 United States Metabolism Drugs Sales Forecast by Application (2017-2022)
11.4 Metabolism Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Metabolism Drugs
Table Classification of Metabolism Drugs
Figure United States Sales Market Share of Metabolism Drugs by Type in 2015
Figure Glycogen Metabolism Disease Drug Picture
Figure Lipid Metabolism Disease Drug Picture
Figure Amino Acid Metabolism Drug Picture
Figure Other Picture
Table Application of Metabolism Drugs
Figure United States Sales Market Share of Metabolism Drugs by Application in 2015
Figure Hospital Examples
Figure Retail Pharmacy Examples
Figure Other Examples
Figure United States Metabolism Drugs Sales and Growth Rate (2012-2022)
Figure United States Metabolism Drugs Revenue and Growth Rate (2012-2022)
Table United States Metabolism Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Metabolism Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Metabolism Drugs Sales Share by Manufacturers
Figure 2016 Metabolism Drugs Sales Share by Manufacturers
Table United States Metabolism Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Metabolism Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Metabolism Drugs Revenue Share by Manufacturers
Table 2016 United States Metabolism Drugs Revenue Share by Manufacturers
Table United States Market Metabolism Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Metabolism Drugs Average Price of Key Manufacturers in 2015
Figure Metabolism Drugs Market Share of Top 3 Manufacturers
Figure Metabolism Drugs Market Share of Top 5 Manufacturers
Table United States Metabolism Drugs Sales by States (2012-2017)
Table United States Metabolism Drugs Sales Share by States (2012-2017)
Figure United States Metabolism Drugs Sales Market Share by States in 2015
Table United States Metabolism Drugs Revenue and Market Share by States (2012-2017)
Table United States Metabolism Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Metabolism Drugs by States (2012-2017)
Table United States Metabolism Drugs Price by States (2012-2017)
Table United States Metabolism Drugs Sales by Type (2012-2017)
Table United States Metabolism Drugs Sales Share by Type (2012-2017)
Figure United States Metabolism Drugs Sales Market Share by Type in 2015
Table United States Metabolism Drugs Revenue and Market Share by Type (2012-2017)
Table United States Metabolism Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Metabolism Drugs by Type (2012-2017)
Table United States Metabolism Drugs Price by Type (2012-2017)
Figure United States Metabolism Drugs Sales Growth Rate by Type (2012-2017)
Table United States Metabolism Drugs Sales by Application (2012-2017)
Table United States Metabolism Drugs Sales Market Share by Application (2012-2017)
Figure United States Metabolism Drugs Sales Market Share by Application in 2015
Table United States Metabolism Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Metabolism Drugs Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Metabolism Drugs Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Metabolism Drugs Sales Market Share (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Pharmaceutical Metabolism Drugs Sales Market Share (2012-2017)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Astra Zeneca Metabolism Drugs Sales Market Share (2012-2017)
Table Beohrigher Ingelheim Basic Information List
Table Beohrigher Ingelheim Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Beohrigher Ingelheim Metabolism Drugs Sales Market Share (2012-2017)
Table KOWA Basic Information List
Table KOWA Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table KOWA Metabolism Drugs Sales Market Share (2012-2017)
Table Kythera Basic Information List
Table Kythera Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kythera Metabolism Drugs Sales Market Share (2012-2017)
Table Fuji yakuhin Basic Information List
Table Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Fuji yakuhin Metabolism Drugs Sales Market Share (2012-2017)
Table LG Life Science Basic Information List
Table LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table LG Life Science Metabolism Drugs Sales Market Share (2012-2017)
Table Metsubishi Tanabe Pharma Basic Information List
Table Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Metsubishi Tanabe Pharma Metabolism Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolism Drugs
Figure Manufacturing Process Analysis of Metabolism Drugs
Figure Metabolism Drugs Industrial Chain Analysis
Table Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2015
Table Major Buyers of Metabolism Drugs
Table Distributors/Traders List
Figure United States Metabolism Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Metabolism Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Metabolism Drugs Production Forecast by Type (2017-2022)
Table United States Metabolism Drugs Consumption Forecast by Application (2017-2022)
Table United States Metabolism Drugs Sales Forecast by States (2017-2022)
Table United States Metabolism Drugs Sales Share Forecast by States (2017-2022)